)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Paul Hartmann
Paul Hartmann (PHH2) investor relations material
Paul Hartmann Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary4 Aug, 2026
Executive summary
Organic revenue grew by 3.3% year-over-year to €1,252.0 million in H1 2026, with all core segments contributing to growth.
Adjusted EBITDA increased by €25.9 million to €151.7 million, with margin rising from 10.4% to 12.1%.
Net income rose sharply to €57.6 million from €18.1 million in the prior year period.
Financial highlights
Revenue: €1,252.0 million, up 3.3% year-over-year.
Adjusted EBITDA: €151.7 million, up from €125.8 million; margin at 12.1%.
EBIT (operating income): €88.3 million, up from €44.4 million.
EPS: €15.35, up from €4.46 year-over-year.
Operating cash flow: €126.2 million, up from €15.7 million.
Outlook and guidance
Expects moderate organic revenue growth and adjusted EBITDA between €270–310 million for FY 2026.
Anticipates higher material, energy, and freight costs in H2 2026 due to the Iran war, with only partial compensation through pricing.
Projects negative impact on 2027 results from new statutory health insurance rules and planned care reform.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Paul Hartmann
- Transformation gains lifted adjusted EBITDA despite weaker infection-management sales.PHH2
Q4 2023 - Q1 2026 delivered higher sales and EBITDA, with positive outlook despite cost headwinds.PHH2Q1 2026
- 2025 saw 2.2% organic sales growth, higher EBITDA, and a stable €8.00 dividend amid market challenges.PHH2Q4 2025
- Organic sales up 2.0% to €1.83bn, EBITDA margin at 10.7%, guidance confirmed.PHH2Q3 2025
- Revenue up 1.6%, but profit and guidance down due to higher costs and market headwinds.PHH2Q2 2025
- Sales and earnings rose across all segments, prompting a raised EBITDA outlook for 2024.PHH2Q3 2024
- Strong H1 2024 results and raised EBITDA outlook reflect successful transformation and growth.PHH2Q2 2024
- Record earnings and margin expansion achieved through transformation and innovation.PHH2Q4 2024
- Q1 2025 saw Hartmann grow revenue and margin, with US and product innovation as key drivers.PHH2Q1 2025
Next Paul Hartmann earnings date
Q3 202618 Nov, 2026
Paul Hartmann
Next Paul Hartmann earnings date
Q3 202618 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Paul Hartmann AG manufactures, markets and sells medical and care products. The company operates across a range of markets, including in Europe, Africa, Asia, and Oceania. It offers disinfectant products for hands, surface, instruments, single-use and pre-surgical products and more. In addition, it markets body care, dietary supplements, and herbal medicinal products; and distributes private-label products, such as cotton/cosmetic, medical, and baby and home care products. The company was founded in 1818 and is based in Heidenheim, Germany.